NCT03830398

Comparison of Drugs on Headache Treatment After ECT Treatment

Comparison of Paracetamol and Dexketoprofen Trometamol on Headache Treatment After Electroconvulsive Treatment

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 225 (estimated)
• Sponsor: Mustafa Kemal University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Electroconvulsive treatment (ECT) is still actual for treatment of psychiatric symptoms. Headache is a very common symptom after this application. The investigators compare the effect of two different drugs for the treatment of headache after ECT.

Detailed description

Electroconvulsive treatment (ECT) is used as an alternative application instead of drug therapy for psychiatric symptoms. ECT application is repeated 8-12 times according to the treatment of the patient. This treatment is done in 2 or 3 days intervals. The most adverse effects of ECT are headache, memory disorders, myalgia, nausea and vomiting, cardiovascular problems. The most common seen adverse effect is headache with approximately 60% incidence. The main drugs used for the treatment of headache related to ECT are NSAIs and paracetamol. The aim of the current study is to compare the effect of paracetamol and dexketoprofen trometamol on headache treatment after ECT.

Conditions

• Mental Disorders

Interventions

Type	Name	Description
DRUG	Paracetamol	The investigators apply paracetamol during a week in preoperative room 45 min before ECT
DRUG	Deksketoprofen trometamol	The investigators apply paracetamol during a week in preoperative room 45 min before ECT
DRUG	Placebo	The investigators apply placebo during a week in preoperative room 45 min before ECT

Timeline

• Start date: 2018-11-20
• Primary completion: 2019-05-01
• Completion: 2019-06-01
• First posted: 2019-02-05
• Last updated: 2019-02-05

Locations

1 site across 1 country: Turkey (Türkiye)